NewLink Genetics Competitors and Similar CompaniesClear all

NewLink Genetics's competitors and similar companies include CytomX Therapeutics, Sirnaomics US and Immodulon Therapeutics.

	NewLink Genetics NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.	CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.	Sirnaomics US Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology.	Immodulon Therapeutics Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.
Founding Date	Founding Date 1999	Founding Date 2008	Founding Date 2007	Founding Date N/A
Type	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Ames, US HQ Austin, US Devens, US	Locations South San Francisco, US HQ	Locations Germantown, US HQ Cambridge, US	Locations Hayes, GB HQ London, GB
Employees	Employees 2162% decrease	Employees 15815% increase	Employees 3211% decrease	Employees 10
Valuation ($)	Valuation ($) 33.2 m	Valuation ($) 78 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $230k (FY, 2021)	Revenue (est.) $76.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($30.4m) (FY, 2021)	Net income ($17.4m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 45.2m	Total funding raised $ 132.4m	Total funding raised $ 162m	Total funding raised N/A